Lisata Therapeutics, Inc.
LSTA· Nasdaq
LSTALisata Therapeutics, Inc.
Released Nov 7, 2013, after the close
10-Q filed Nov 7, 2013, 38 days after period end · 0000320017-13-000111
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2012 | Q3 2011 | Q3 2010 | Q3 2009 |
|---|---|---|---|---|
| Revenue | — | $4.43M | $2.18M | $16.48M |
| Net Income | -$9.07K | -$8.41M | -$7.35M | -$7.14M |
| EPS Diluted | -$0.45 |
Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR
| -$0.64 |
| -$0.08 |
| -$0.13 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
